These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31531163)

  • 1. An Analysis of Marketing Trends for the Approval of Cryolipolysis Devices by the United States Food and Drug Administration.
    Wang S; Ezaldein H; Tripathi R; Merati M; Scott J
    J Clin Aesthet Dermatol; 2019 Jul; 12(7):59-60. PubMed ID: 31531163
    [No Abstract]   [Full Text] [Related]  

  • 2. Literature review of adverse events associated with cryolipolysis.
    Deligonul FZ; Yousefian F; Gold MH
    J Cosmet Dermatol; 2023 Nov; 22 Suppl 3():31-36. PubMed ID: 37988712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shedding light on the FDA's 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia.
    Wang S; Seth D; Ezaldein H; Tripathi R; Merati M; Muakkassa F; Scott J
    J Dermatolog Treat; 2019 Aug; 30(5):489-491. PubMed ID: 30252550
    [No Abstract]   [Full Text] [Related]  

  • 4. Powered muscle stimulators: an investigation into newly FDA 510(k) approved devices marketed for muscle toning and esthetic benefit.
    Manudhane AP; Wang S; Ezaldein HH; Scott JF
    J Dermatolog Treat; 2020 Mar; 31(2):200-203. PubMed ID: 30799667
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United States Food and Drug Administration's 510(k) Pathway: Drawing Implications from the Approvals of Brachytherapy Devices.
    Wang S; Manudhane A; Ezaldein HH; Scott JF
    Cureus; 2019 Mar; 11(3):e4230. PubMed ID: 31123652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
    Tylenda CA; Weintraub M
    Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the FDA's 510(k) approvals process for electromagnetic devices used in body contouring.
    Wang S; Manudhane A; Ezaldein HH; Scott JF
    J Dermatolog Treat; 2019 Nov; 30(7):727-729. PubMed ID: 30614316
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.
    Chang L; Dhruva SS; Chu J; Bero LA; Redberg RF
    BMJ; 2015 Jun; 350():h2613. PubMed ID: 26063311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM; Rathi VK; Grauer JN; Ross JS
    Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical application of cryolipolysis in Asian patients for subcutaneous fat reduction and body contouring.
    Oh CH; Shim JS; Bae KI; Chang JH
    Arch Plast Surg; 2020 Jan; 47(1):62-69. PubMed ID: 31964125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryolipolysis: Clinical Best Practices and Other Nonclinical Considerations.
    Few J; Saltz R; Beaty M; Kelly M; Movassaghi K; Marcus KA; Sieber D; Burns AJ; Sangha S
    Aesthet Surg J Open Forum; 2020 Jun; 2(2):ojaa010. PubMed ID: 33791637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasound cavitation versus cryolipolysis for non-invasive body contouring.
    Mahmoud ELdesoky MT; Mohamed Abutaleb EE; Mohamed Mousa GS
    Australas J Dermatol; 2016 Nov; 57(4):288-293. PubMed ID: 26299702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryolipolysis for safe and effective inner thigh fat reduction.
    Zelickson BD; Burns AJ; Kilmer SL
    Lasers Surg Med; 2015 Feb; 47(2):120-7. PubMed ID: 25586980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryolipolysis for the treatment of submental fat: Review of the literature.
    Lipner SR
    J Cosmet Dermatol; 2018 Apr; 17(2):145-151. PubMed ID: 29345049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
    BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of Paradoxical Adipose Hyperplasia (PAH) Post-Cryolipolysis.
    Ho D; Jagdeo J
    J Drugs Dermatol; 2017 Jan; 16(1):62-67. PubMed ID: 28095535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryolipolysis for reduction of excess adipose tissue.
    Nelson AA; Wasserman D; Avram MM
    Semin Cutan Med Surg; 2009 Dec; 28(4):244-9. PubMed ID: 20123423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Internally Controlled Blind Reviewed Clinical Evaluation of Cryolipolysis Combined With Multipolar Radiofrequency andVaripulseTechnology for Enhanced Subject Results in Circumferential Fat Reduction and Skin Laxity of the Flanks.
    Few J; Gold M; Sadick N
    J Drugs Dermatol; 2016 Nov; 15(11):1354-1358. PubMed ID: 28095547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient Satisfaction, Recommendation Rate, and Patient Comfort With an FDA-Cleared Cryolipolysis System.
    Altmann J; Jehle F; Mang W
    Aesthet Surg J Open Forum; 2022; 4():ojac067. PubMed ID: 36211478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.